Table 2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank
Collister JA., Liu X., Littlejohns TJ., Cuzick J., Clifton L., Hunter DJ.
<p>Breakdown of case and control classification in the test data (<i>N</i> = 25,369) using 10-year risks from the Tyrer-Cuzick model with and without PRS<sub>BC</sub>, with a fixed proportion (6.47%) of women considered at “moderate risk”.</p>